TerelNewton.com

pain-management routes/procedures, with medical necessity:

Oral — medically necessary for generalized, multi-site, or persistent pain when systemic therapy is appropriate, conservative medication management is indicated, and expected functional benefit outweighs potential medication risks.
Topical — medically necessary for localized pain, strain, or focal soft-tissue symptoms to target the affected region directly while reducing oral medication use and minimizing systemic side effects.
Transdermal — medically necessary when steady systemic medication delivery is required, especially when oral therapy is poorly tolerated, contraindicated, unreliable, or impractical for consistent pain control.
Trigger point injections — medically necessary for focal myofascial pain with palpable trigger points, muscle spasm, or taut bands when symptoms persist despite conservative care such as stretching, therapy, heat/ice, or medication.
Joint injections — medically necessary for suspected intra-articular pain, inflammation, or degenerative joint pathology when history, examination, and/or imaging support the joint as a pain generator.
Facet injections / MBB / RFA — medically necessary for suspected facet-mediated axial neck or back pain. Diagnostic medial branch blocks help confirm the pain source; RFA is considered after positive diagnostic response.
Epidural injections — medically necessary for radicular neck, thoracic, or low back pain when symptoms correlate with examination and/or imaging findings and conservative treatment has not provided adequate relief.
IM/subcutaneous — medically necessary for short-term medication delivery when oral therapy is not feasible, poorly tolerated, or when faster onset is clinically needed in an appropriate monitored setting.
IV — medically necessary for acute severe pain, procedural analgesia/sedation, peri-procedural medication administration, or monitored care when rapid titration and close clinical observation are required.
Intrathecal — medically necessary for severe refractory chronic pain requiring targeted spinal drug delivery after failure, intolerance, or inadequate response to less invasive treatments and systemic medication options.

L0631 lumbar-sacral orthosis: Recommended after MVA for lower back pain/strain with impaired mobility. Medically necessary to provide lumbar support, reduce painful motion, decrease lumbar disc/joint loading, improve stability, and assist ADLs during recovery.

L0637 mid/lower back orthosis: Recommended after MVA for mid and lower back pain/strain with impaired mobility or instability. Medically necessary to support the thoracic-lumbar-sacral region, limit painful motion, reduce spinal loading, improve posture, and assist ADLs during recovery.

Wrist brace: Recommended after MVA for wrist pain, sprain/strain, tendon irritation, or suspected soft-tissue injury. Medically necessary to immobilize/support the wrist, reduce painful motion, decrease inflammation, protect injured tissues, and improve hand function during recovery.

Knee brace: Recommended after MVA for knee pain, sprain/strain, instability, swelling, or suspected ligament/meniscal irritation. Medically necessary to provide support, improve joint stability, limit painful motion, reduce stress on injured tissues, and assist ambulation.

Physical therapy: Recommended after MVA for cervical/thoracic/lumbar pain, strain, spasm, ROM loss, weakness, and functional limitation. Medically necessary to restore mobility, improve strength, reduce pain, correct mechanics, and reduce need for medications/procedures.

Occipital nerve block: Recommended for post-MVA occipital headache/neck pain consistent with occipital neuralgia or cervicogenic headache. Medically necessary when symptoms persist despite conservative care to reduce nerve-mediated pain and improve function.

Medical cannabis — pain: May be considered for chronic or refractory post-traumatic pain when standard therapies are ineffective, poorly tolerated, or contraindicated, with goal of reducing pain, improving function, sleep, and minimizing opioid/oral medication burden.

Medical cannabis — anxiety/PTSD: May be considered for anxiety/PTSD symptoms after trauma when clinically appropriate and allowed by state law, particularly when symptoms impair sleep, mood, or function and conventional treatment is inadequate or poorly tolerated.

Medical cannabis — cancer pain: May be considered for cancer-related pain, nausea, appetite loss, or treatment-related symptoms when standard therapies provide inadequate relief or cause limiting side effects, with goal of improving comfort, function, and quality of life.

PRP injection: Recommended for persistent post-MVA tendon, ligament, joint, or soft-tissue pain when conservative care has failed. Medically necessary to promote autologous tissue healing, reduce inflammation, improve function, and potentially reduce need for steroids, opioids, or surgery. Evidence is evolving and varies by condition.

Neurogenx treatment: May be considered for neuropathic pain, burning, tingling, numbness, or neuromuscular discomfort after trauma when symptoms persist despite conservative care. Medically necessary when used to provide non-invasive neuromodulation, reduce neuropathic symptoms, improve function, and decrease medication burden. Neurogenx markets its system as FDA-cleared and non-invasive, but independent evidence should be considered condition-specific.

Peripheral nerve stimulation, PNS: Recommended for focal chronic neuropathic or post-traumatic nerve pain after failed conservative treatment, injections, or medications. Medically necessary to target the involved peripheral nerve, reduce pain signaling, improve activity tolerance, and limit reliance on systemic medications.

Spinal cord stimulation, SCS: Recommended for refractory neck, back, limb, radicular, or neuropathic pain when conservative care, medications, therapy, and appropriate injections have failed. Medically necessary to provide neuromodulation for chronic pain, improve function, reduce opioid reliance, and avoid or delay more invasive surgery when appropriate.

Dorsal root ganglion stimulation, DRG: Recommended for focal neuropathic pain, CRPS-type symptoms, or regional post-traumatic pain not controlled with standard treatment. Medically necessary to provide targeted neuromodulation at the affected nerve root level, improving pain control and function in anatomically localized pain patterns.

Low-level laser therapy / photobiomodulation: May be considered for persistent soft-tissue pain, strain, inflammation, or neuropathic symptoms after MVA. Medically necessary as a non-invasive adjunct to reduce pain, support tissue recovery, improve circulation, and assist function when standard conservative care is incomplete.

Extracorporeal shockwave therapy: May be considered for chronic tendon, ligament, myofascial, or insertional pain that persists after therapy and medication. Medically necessary to stimulate local tissue healing, reduce chronic pain, improve mobility, and avoid repeated medication or steroid exposure.

Prolotherapy: May be considered for suspected ligamentous laxity, chronic sprain/strain, or joint instability after MVA when symptoms persist despite bracing, therapy, and medication. Medically necessary to stimulate a localized healing response, improve stability, reduce pain, and enhance functional tolerance.

Ketamine infusion: May be considered for severe refractory neuropathic pain, CRPS-like symptoms, or centralized pain after trauma when standard treatments fail. Medically necessary only in a monitored setting to reduce severe pain amplification, improve function, and decrease dependence on higher-risk medications.

Radiofrequency ablation, RFA: Recommended for chronic facet-mediated neck, thoracic, or lumbar pain after positive diagnostic medial branch blocks. Medically necessary to interrupt pain transmission from confirmed facet pain generators, improve function, and reduce ongoing medication or injection needs.

Page updated

Google Sites

Report abuse